Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Obstructive Lung Diseases

  Free Subscription


23.12.2018

1 Am J Respir Cell Mol Biol
5 Am J Respir Crit Care Med
2 Ann Allergy Asthma Immunol
1 Arch Bronconeumol
8 Eur Respir J
1 J Allergy Clin Immunol
1 J Asthma
2 J Investig Allergol Clin Immunol
3 Lancet Respir Med
1 PLoS Med
2 PLoS One
1 Proc Natl Acad Sci U S A
2 Respir Res
1 Thorax


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Respir Cell Mol Biol

  1. PATEL KJ, Cheng Q, Stephenson S, Allen DP, et al
    Emphysema Associated Autoreactive Antibodies Exacerbate Post Lung Transplant Ischemia Reperfusion Injury.
    Am J Respir Cell Mol Biol. 2018 Dec 20. doi: 10.1165/rcmb.2018-0224.
    PubMed     Text format     Abstract available


    Am J Respir Crit Care Med

  2. LAJUNEN K, Kalliola S, Kotaniemi-Syrjanen A, Malmberg LP, et al
    Environmental Tobacco Smoke Affects Lung Function of Asthmatic Preschoolers Even After a Decade.
    Am J Respir Crit Care Med. 2018 Dec 18. doi: 10.1164/rccm.201809-1729.
    PubMed     Text format    

  3. SERBAN KA, Mikosz A, Strange C, Janciauskiene SM, et al
    Lectin Complement Pathway in Emphysema.
    Am J Respir Crit Care Med. 2018 Dec 17. doi: 10.1164/rccm.201807-1380.
    PubMed     Text format    

  4. SAGLANI S, Custovic A
    Childhood Asthma: Advances Using Machine Learning and Mechanistic Studies.
    Am J Respir Crit Care Med. 2018 Dec 20. doi: 10.1164/rccm.201810-1956.
    PubMed     Text format     Abstract available

  5. HULL JH, Walsted ES, Backer V, Pavitt MJ, et al
    High Prevalence of Laryngeal Obstruction during Exercise in Severe Asthma.
    Am J Respir Crit Care Med. 2018 Dec 20. doi: 10.1164/rccm.201809-1734.
    PubMed     Text format    

  6. RAMSAHAI JM, Hansbro PM, Wark PAB
    Mechanisms and Management of Asthma Exacerbations.
    Am J Respir Crit Care Med. 2018 Dec 18. doi: 10.1164/rccm.201810-1931.
    PubMed     Text format     Abstract available


    Ann Allergy Asthma Immunol

  7. ELDEIRAWI K, Kunzweiler C, Zenk S, Finn P, et al
    Associations of urban greenness with asthma and respiratory symptoms in Mexican American children.
    Ann Allergy Asthma Immunol. 2018 Dec 14. pii: S1081-1206(18)31529.
    PubMed     Text format    

  8. KOZIK AJ, Huang YJ
    The Microbiome in Asthma: Role in pathogenesis, phenotype, and response to treatment.
    Ann Allergy Asthma Immunol. 2018 Dec 12. pii: S1081-1206(18)31525.
    PubMed     Text format    


    Arch Bronconeumol

  9. PICADO C, Pernigotti A, Arismendi E
    Asthma: A New Cardiovascular Risk Factor?
    Arch Bronconeumol. 2018 Dec 14. pii: S0300-2896(18)30414.
    PubMed     Text format    


    Eur Respir J

  10. BEASLEY R, Braithwaite I, Fingleton J, Weatherall M, et al
    The inhaled corticosteroid/long-acting beta-agonist maintenance and reliever therapy regimen: where to from here?
    Eur Respir J. 2018;51.
    PubMed     Text format    

  11. CLINI E, Castaniere I, Tonelli R
    Looking for a chronic care model in COPD patients.
    Eur Respir J. 2018;51.
    PubMed     Text format    

  12. SOHAL SS
    Inhaled corticosteroids and increased microbial load in COPD: potential role of epithelial adhesion molecules.
    Eur Respir J. 2018;51.
    PubMed     Text format    

  13. JONES R
    The scale of the problem of obstructive lung disease in Africa becomes clearer, but where are the solutions?
    Eur Respir J. 2018;51.
    PubMed     Text format    

  14. HALPIN DMG
    Palliative care for people with COPD: effective but underused.
    Eur Respir J. 2018;51.
    PubMed     Text format    

  15. CRINER GJ
    Revising our approach to conducting therapeutic clinical research in COPD.
    Eur Respir J. 2018;51.
    PubMed     Text format    

  16. SIMILOWSKI T
    Treat the lungs, fool the brain and appease the mind: towards holistic care of patients who suffer from chronic respiratory diseases.
    Eur Respir J. 2018;51.
    PubMed     Text format    

  17. SORIANO JB, Burgel PR
    On Don Quixote and pink puffers: multi-organ loss of tissue COPD.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    J Allergy Clin Immunol

  18. BIAGINI MYERS JM, Schauberger E, He H, Martin LJ, et al
    A Pediatric Asthma Risk Score to better predict asthma development in young children.
    J Allergy Clin Immunol. 2018 Dec 7. pii: S0091-6749(18)31577.
    PubMed     Text format     Abstract available


    J Asthma

  19. TAN DJ, Burgess JA, Perret JL, Bui DS, et al
    Non-pharmacological management of adult asthma in Australia: cross-sectional analysis of a population-based cohort study.
    J Asthma. 2018 Dec 20:1-8. doi: 10.1080/02770903.2018.1545030.
    PubMed     Text format     Abstract available


    J Investig Allergol Clin Immunol

  20. BOBOLEA I, Arismendi E, Valero A, Agusti A, et al
    Early Life Origins of Asthma: A Review of Potential Effectors.
    J Investig Allergol Clin Immunol. 2018 Dec 18:0. doi: 10.18176/jiaci.0361.
    PubMed     Text format     Abstract available

  21. MARQUES-MEJIAS MA, Tomas-Perez M, Hernandez I, Lopez I, et al
    Asthma Exacerbations in the Pediatric Emergency Department at a Tertiary Hospi-tal: Relationship with Environmental Factors.
    J Investig Allergol Clin Immunol. 2018 Dec 18:0. doi: 10.18176/jiaci.0364.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  22. ASHER I, Bissell K, Chiang CY, El Sony A, et al
    Calling time on asthma deaths in tropical regions-how much longer must people wait for essential medicines?
    Lancet Respir Med. 2018 Dec 12. pii: S2213-2600(18)30513.
    PubMed     Text format    

  23. NADIF R
    Genetic insights into moderate-to-severe asthma.
    Lancet Respir Med. 2018 Dec 11. pii: S2213-2600(18)30447.
    PubMed     Text format    

  24. SHRINE N, Portelli MA, John C, Soler Artigas M, et al
    Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study.
    Lancet Respir Med. 2018 Dec 11. pii: S2213-2600(18)30389.
    PubMed     Text format     Abstract available


    PLoS Med

  25. KEAG OE, Norman JE, Stock SJ
    Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: Systematic review and meta-analysis.
    PLoS Med. 2018;15:e1002494.
    PubMed     Text format     Abstract available


    PLoS One

  26. KIM YM, Kim J, Cheong HK, Jeon BH, et al
    Exposure to phthalates aggravates pulmonary function and airway inflammation in asthmatic children.
    PLoS One. 2018;13:e0208553.
    PubMed     Text format     Abstract available

  27. OSORIO-VALENCIA JS, Wongviriyawong C, Winkler T, Kelly VJ, et al
    Elevation in lung volume and preventing catastrophic airway closure in asthmatics during bronchoconstriction.
    PLoS One. 2018;13:e0208337.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  28. LIN W, Su F, Gautam R, Wang N, et al
    Raf kinase inhibitor protein negatively regulates FcepsilonRI-mediated mast cell activation and allergic response.
    Proc Natl Acad Sci U S A. 2018 Oct 3. pii: 1805474115.
    PubMed     Text format     Abstract available


    Respir Res

  29. BHATT SP, Nath HP, Kim YI, Ramachandran R, et al
    Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.
    Respir Res. 2018;19:257.
    PubMed     Text format     Abstract available

  30. GAFAR F, Boudewijn IM, Cox CA, Vonk JM, et al
    Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Respir Res. 2018;19:256.
    PubMed     Text format     Abstract available


    Thorax

  31. WANG Z, Singh R, Miller BE, Tal-Singer R, et al
    Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
    Thorax. 2018;73:331-338.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: